HIGHMARK WEALTH MANAGEMENT LLC – Halozyme Therapeutics, Inc. Transaction History
HIGHMARK WEALTH MANAGEMENT LLC portfolio value:
$1.91M
portfolio value
HIGHMARK WEALTH MANAGEMENT LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.39% | -1.7K shares | -291K | $39.54 | 48.49K |
| Q2 2022 | share | Increase | +1.01% | 500 shares | 226K | $44 | 50.19K |
| Q1 2022 | share | Decrease | -5.51% | -2.9K shares | -133K | $39.88 | 49.69K |
| Q4 2021 | share | Decrease | -1.41% | -751 shares | -55K | $40.32 | 52.59K |
| Q3 2021 | share | Decrease | -0.22% | -116 shares | -257K | $40.68 | 53.34K |
| Q2 2021 | share | Increase | +25.16% | 10.74K shares | 1.48M | $45.41 | 53.45K |
| Q1 2021 | share | Increase | +92.87% | 20.56K shares | 1K | $41.69 | 42.71K |
| Q4 2020 | share | Decrease | -19.51% | -5.36K shares | 223K | $42.71 | 22.14K |
| Q3 2020 | share | Increase | +4159.29% | 26.86K shares | 706K | $26.28 | 27.51K |
| Q2 2020 | share | Increase | 0.00% | 646 shares | 17K | $26.81 | 646 |